Thanks Oxxa yes that's correct my point was there are now lots...

Thanks Oxxa yes that's correct my point was there are now lots in that space, the link below (11/2023) is from an aussie uni and even uses the term "Paradigm shift in Osteoarthritis treatment" and it ain't PAR. Point being it is hard to capture a chunk of market share when so many others are in the space, we have been around for ages and done zip, no partners no license agreements can't even explain to the FDA what is the OBD, FFS.

Sadly I think the ship has sailed, we will need a massive capital raise probably south of where SP is today to finish a trial we can't confirm yet, dilution will be big if they can even do it, Aussie Biotechs aren't really the flavor of the month, and with people like PR at the helm one can see why.

Keep raising keep the high salaries keep raising keep the high salaries flowing till the well is dry very common play book unfortunately.

Sorry for my negativity just can't see any miracles on the horizon even if FDA sanction what should be a known, won't change much won't put $ in the kitty.

Osteoarthritis Breakthrough: New Research Shows That the Condition May Be Treatable and Reversible (scitechdaily.com)